CARMAT |
Market Closed -
Other stock markets
|
Pre-market 02:55:19 am | |||
| 3.04 EUR | -1.78% |
|
3.033 | -0.23% |
| May. 17 | Oddo BHF Cuts Carmat PT, Affirms Neutral Rating | MT |
| May. 17 | CARMAT : price target lowered by Oddo BHF | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Calendar
2024-05-29
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.04
EUR
Average target price
12.98
EUR
Spread / Average Target
+326.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -54.63% | 96.15M | |
| +10.11% | 126B | |
| -5.15% | 11.33B | |
| +6.07% | 9.27B | |
| +37.46% | 5.5B | |
| +8.53% | 3.45B | |
| -8.69% | 2.81B | |
| -6.38% | 2.08B | |
| -10.91% | 2.09B | |
| -23.21% | 1.78B |
- Stock Market
- Equities
- ALCAR Stock
- News CARMAT
- Carmat Launches New Artificial Heart Production Plant in France; Shares Soar